On November 9, 2026 Redx Pharma Ltd ("Redx" or the "Company"), a clinical-stage biotechnology company focused on developing novel, small molecule, targeted medicines for fibrotic disease, reported participation by Lisa Anson, Chief Executive Officer, Peter Collum, Chief Financial Officer, and Mei-Lun Wang, M.D., Chief Medical Officer, at the following healthcare investor conferences in November.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

UBS Global Biopharma Conference
Date: November 16 and 17, 2026
Location: London, UK
Presentation: 12:40 p.m. GMT
Format: In-person company presentation; 1×1 investor meetings
Webcast: Link here

Jefferies Global Healthcare Conference
Dates: November 18 and 19, 2026
Location: London, UK
Format: 1×1 investor meetings

A live webcast of the UBS presentation will be accessible via the link above. A replay will be available following the live event in the Investors section of the Company’s website at www.redxpharma.com and will be archived for a limited time.

(Press release, Redx Pharma, NOV 9, 2026, View Source [SID1234674606])